Literature DB >> 12164599

Hypocholesterolemia in Nigerian children with sickle cell disease.

Dorothy J VanderJagt1, Jaimie Shores, Anthony Okorodudu, Seline N Okolo, Robert H Glew.   

Abstract

Reports of circulating lipids of children with sickle cell disease (SCD) in Nigeria disagree on the question of whether these children are at increased risk of cardiovascular disease (CVD). We therefore analyzed the serum of 40 females and 37 males with SCD, age 5-19 years, and equal numbers of age-matched controls for total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, and homocysteine. Using bioelectrical impedance analysis, we documented a significant reduction in the per cent fat-free mass in the SCD males and increases in the per cent body fat in both the male and female children with SCD. Marked hypocholesterolemia was present in both genders (means, 100-102 mg/dl) and the LDL-cholesterol levels of the male and female subjects with SCD (54 mg/dl) were below the lower limit of the reference range (59-137 mg/dl). Serum triglycerides in the SCD subjects were in the middle of the reference range for children. Although the mean HDL-cholesterol levels of the SCD males (23.1 mg/dl) and females (24.5 mg/dl) were well below the lower limit of the reference range (35-84 mg/dl), respectively, the LDL-cholesterol/HDL-cholesterol ratios of the SCD subjects were not abnormal. The mean serum homocysteine concentrations of the male and female SCD subjects (9.4-9.6 micromol/l) were at the high end of the normal range. Collectively, these results indicate that children with SCD in northern Nigeria are not at increased risk of CVD. However, their marked hypocholesterolemia should be a cause of concern about the overall mortality and general well-being.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164599     DOI: 10.1093/tropej/48.3.156

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  14 in total

1.  Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.

Authors:  Oktay H Ozturk; Yesim Can; Zafer Yonden; Sedat Motor; Gonul Oktay; Hasan Kaya; Mutay Aslan
Journal:  Lipids       Date:  2013-10-11       Impact factor: 1.880

2.  Hypocholesterolemia is associated negatively with hemolysate lipid peroxidation in sickle cell anemia patients.

Authors:  Y E Oztas; Oztas Er Yesim; S Sabuncuoglu; Sabuncuoglu Suna; S Unal; Unal Selma; H Ozgunes; Ozgunes Hilal; N Ozgunes; Ozgunes Nuriman
Journal:  Clin Exp Med       Date:  2010-12-30       Impact factor: 3.984

Review 3.  The proteome of sickle cell disease: insights from exploratory proteomic profiling.

Authors:  Susan Yuditskaya; Anthony F Suffredini; Gregory J Kato
Journal:  Expert Rev Proteomics       Date:  2010-12       Impact factor: 3.940

4.  Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease.

Authors:  Magda O Seixas; Larissa C Rocha; Mauricio B Carvalho; Joelma F Menezes; Isa M Lyra; Valma M L Nascimento; Ricardo D Couto; Ájax M Atta; Mitermayer G Reis; Marilda S Goncalves
Journal:  Lipids Health Dis       Date:  2010-08-27       Impact factor: 3.876

5.  Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.

Authors:  Ayla Yalamanoglu; Jeremy W Deuel; Ryan C Hunt; Jin Hyen Baek; Kathryn Hassell; Katie Redinius; David C Irwin; Dominik J Schaer; Paul W Buehler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-26       Impact factor: 5.464

6.  Hypocholesterolemia and nonregenerative, suspected immune-mediated, anemia: Report of 3 canine cases.

Authors:  Rachel Robbins; Katrina R Viviano
Journal:  Can Vet J       Date:  2017-10       Impact factor: 1.008

7.  Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease.

Authors:  Susan Yuditskaya; Ashaunta Tumblin; Gerard T Hoehn; Guanghui Wang; Steven K Drake; Xiuli Xu; Saixia Ying; Amy H Chi; Alan T Remaley; Rong-Fong Shen; Peter J Munson; Anthony F Suffredini; Gregory J Kato
Journal:  Blood       Date:  2008-11-20       Impact factor: 22.113

8.  Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine.

Authors:  Fekri Samarah; Mahmoud A Srour; Kamal Dumaidi
Journal:  Biomed Res Int       Date:  2021-08-04       Impact factor: 3.411

9.  Hydroxyurea therapy mobilises arachidonic Acid from inner cell membrane aminophospholipids in patients with homozygous sickle cell disease.

Authors:  A A Daak; K Ghebremeskel; M I Elbashir; A Bakhita; Z Hassan; M A Crawford
Journal:  J Lipids       Date:  2011-09-15

10.  Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease.

Authors:  Kenneth I Ataga; Alan Hinderliter; Julia E Brittain; Susan Jones; Hao Xu; Jianwen Cai; Soyoung Kim; Kirkwood A Pritchard; Cheryl A Hillery
Journal:  Hematology       Date:  2014-05-06       Impact factor: 2.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.